| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |